Home › Impeksyon ng Adenoviridae › Ohio
Pag-aaral pangklinika para sa Impeksyon ng Adenoviridae sa Ohio
7 pag-aaral para sa Impeksyon ng Adenoviridae ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
- Nationwide Children's Hospital, Columbus
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 85 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03665675Donor-Derived Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruitPhase 1/2
4 Weeks · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
Nagre-recruitPhase 2
2 Days · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02532452A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- University of Cincinnati Cancer Center, Cincinnati
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07544589A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 3
2 Months · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07387367Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
- Nationwide Children's Hosptial, Columbus
Nagre-recruitPhase 2
1 Month – 79 Years · Lahat ng kasarian · Na-update Ago 8, 2025 · NCT03266627Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections
- Nationwide Children's Hospital, Columbus
Nagre-recruitPhase 1/2
Hanggang edad 60 · Lahat ng kasarian · Na-update May 13, 2025 · NCT04722029Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.